Clinical trial protocols lay the foundation for R&D, but they aren’t enough to ensure success. People, processes, and ...

In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in ...

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

This study used surveys and live interviews. Forty-one major industry and National Cancer Institute Network groups (sponsors) overseeing anticancer treatment trials open in the United States from ...

Tissue biopsies can be important parts of testing new drugs, and the FDA has now issued a draft guidance with recommendations for when they should be included in clinical trial protocols. The draft ...

As clinical trials grow more complex, the technology infrastructure supporting them is under renewed scrutiny. Across data ...

The lack of a mechanism to measure the workload involved in a clinical trials protocol was identified and confirmed by a literature review. To collect information on how Ontario sites were assessing ...

The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the conversion of Healthcare Providers (HCPs) to ...

The CTR came into effect in the EU on January 31st, 2023, to replace the EU Clinical Trials Directive (CTD) with a goal of harmonizing the submission and review of clinical trials in the EU and ...